Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jaguar Health (JAGX) Short term Debt (2016 - 2017)

Jaguar Health (JAGX) has disclosed Short term Debt for 3 consecutive years, with $1.6 million as the latest value for Q4 2017.

  • On a quarterly basis, Short term Debt fell 16.17% to $1.6 million in Q4 2017 year-over-year; TTM through Dec 2017 was $1.6 million, a 16.17% decrease, with the full-year FY2017 number at $1.6 million, down 16.17% from a year prior.
  • Short term Debt was $1.6 million for Q4 2017 at Jaguar Health, down from $1.8 million in the prior quarter.
  • In the past five years, Short term Debt ranged from a high of $2.1 million in Q1 2016 to a low of $21244.0 in Q1 2015.
  • A 3-year average of $1.6 million and a median of $1.8 million in 2017 define the central range for Short term Debt.
  • Peak YoY movement for Short term Debt: surged 9878.02% in 2016, then fell 16.17% in 2017.
  • Jaguar Health's Short term Debt stood at $1.7 million in 2015, then rose by 12.4% to $1.9 million in 2016, then decreased by 16.17% to $1.6 million in 2017.
  • Per Business Quant, the three most recent readings for JAGX's Short term Debt are $1.6 million (Q4 2017), $1.8 million (Q3 2017), and $2.1 million (Q2 2017).